Tumors are ugly. But the staff at Massachusetts General Hospital takes a snapshot of almost every one that crosses the doorstep.
Michael Morgenstern
TUMOR TESTING DREAMS | Though some patients do benefit from drugs that target specific cancer-causing mutations, in most cases a tumor’s underlying mutations are unknown.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.